23 reports

ONE UNIT REFERS TO ONE PROBE.

  • Endoscopic Device
  • East Asia
  • South Korea
  • Market Size
  • CareDx, Inc.

ONE UNIT REFERS TO ONE PROBE.

  • Asthma
  • Endoscopic Device
  • Northern Europe
  • United Kingdom
  • Market Size

ANTIVIRALS ARE GIVEN TO HIGH-EXACERBATION-RISK INDIVIDUALS WHO ARE OVER ## YEARS OLD DURING THE FLU EPIDEMIC SEASON TO FURTHER PREVENT EXACERBATION AND TO IMPROVE QOL.

  • Asthma
  • Australia
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • Vendor landscape

It also signed a deal worth $## billion with Moderna Therapeutics for its messenger RNA therapeutics platform in developing new antiviral vaccines and passive immunity therapies.

  • Asthma
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Cough and cold held a nominal share of ##%.

  • Asthma
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG

Part ## of the trial generated good safety data and additionally demonstrated that SNG## significantly elevates antiviral biomarkers in the lungs of COPD patients.

  • Asthma
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Synairgen plc

One unit refers to one dura substitute.

  • Endoscopic Device
  • Health Services
  • Germany
  • Company
  • Market Segment

Increased environmental pollution Expected launch of personalized medicine High prevalence of asthma Promising late-stage pipeline molecules Expected launch of personalized medicine Increased environmental pollution Low Low ## ## ## ## ## High High ## ## ## ## ## ## ## ## ## ##

  • Asthma
  • United States
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc

One unit refers to one dura substitute.

  • Endoscopic Device
  • United States
  • Company
  • Company Financials
  • Stryker Corporation

ONE UNIT REFERS TO ONE CLIP.

  • Endoscopic Device
  • Hospital
  • Germany
  • Western Europe
  • Stryker Corporation
  • ANTIBODY TO INHIBIT IL-33 FOR ASTHMA - DRUG PROFILE
  • ASTHMA - PIPELINE BY ZAI LAB LTD, H2 2018

The company offers API' s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, betalactase inhibitors, PEGlyated compounds and anti-histamines.

  • Asthma
  • United States
  • Company
  • Product Initiative
  • AstraZeneca PLC

ONE UNIT REFERS TO ONE PROBE.

  • Endoscopic Device
  • Hospital
  • Germany
  • Western Europe
  • Market Size

One unit refers to one dura substitute.

  • Endoscopic Device
  • United Kingdom
  • Company
  • Market Segment
  • Medtronic, Inc.
  • Research and Development Brief
  • ASTHMA - PIPELINE BY LONGEVITY BIOTECH INC, H1 2018

Its products line is at preclinical stage and focuses on cardiovascular, antiviral, neuroscience, metabolic and oncological areas.

  • Asthma
  • Pharmaceutical
  • Research And Development
  • Therapy
  • AstraZeneca PLC

The changes took effect on ## October 2018 and ## January 2019.

  • Asthma
  • Clinical Trial
  • Pulmonary Delivery
  • United States
  • Novartis AG

MYRCLUDEX HAS SHOWN AN EXCELLENT SAFETY PROFILE AND ANTIVIRAL EFFICACY IN SEVERAL CLINICAL TRIALS.

  • Asthma
  • Endoscopic Device
  • Hospital
  • Medical Device
  • Market Size

One unit refers to one clip.

  • Asthma
  • Endoscopic Device
  • Neurology
  • Patient Monitoring
  • AorTech International plc
  • IDIOPATHIC PULMONARY FIBROSIS - PIPELINE BY REDX PHARMA PLC, H1 2018

Its proprietary redox switch is employed to generate novel antiviral and antibacterial drugs in the region of infectious disease.

  • Asthma
  • Autoimmune Disease
  • United States
  • Product Initiative
  • ProMetic Life Sciences Inc.
  • ASTHMA - PIPELINE BY XENCOR INC

Its proprietary redox switch is employed to generate novel antiviral and antibacterial drugs in the region of infectious disease.

  • Asthma
  • Pharmaceutical
  • Company
  • Product Initiative
  • AstraZeneca PLC

The prominent features of this report are - ##.

  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World
  • ALLERGIC ASTHMA - PIPELINE BY MARINOMED BIOTECHNOLOGIE GMBH, H2 2016
  • BETA-ESCIN - DRUG PROFILE

It utilizes antiviral respiratory technology platform MAVIREX and develops therapies.

  • Asthma
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Infinity Pharmaceuticals, Inc.
  • Rhinovirus Infection - Product Development Milestones

The design, synthesis and biological evaluation of antiviral compounds acting against human rhinovirus (HRV) was investigated. ##d-##, ##d-##, ##f showed good exposures in CD-## mice.

  • Asthma
  • Infectious Disease
  • Therapy
  • United States
  • Company Operations
  • ALLERGIC ASTHMA - PIPELINE BY MARINOMED BIOTECHNOLOGIE GMBH, H1 2016

It utilizes antiviral respiratory technology platform MAVIREX and develops therapies.

  • Asthma
  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • Infinity Pharmaceuticals, Inc.